BioLife Solutions, Inc. (NASDAQ:BLFS) Receives $31.17 Average PT from Analysts
BioLife Solutions, Inc. (NASDAQ:BLFS – Get Free Report) has earned a consensus recommendation of “Buy” from the six analysts that are presently covering the company, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have issued ratings on the stock in the last […]
BioLife Solutions, Inc. (NASDAQ:BLFS – Get Free Report) has earned a consensus recommendation of “Buy” from the six analysts that are presently covering the company, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have issued ratings on the stock in the last […]
